Anthem Biosciences Limited header image

Anthem Biosciences Limited

544449

Equity

ISIN INE0CZ201020 / Valor 146882011

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-01)
INR 923.15+3.55%

Anthem Biosciences Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Anthem Biosciences Limited is a Bangalore-based contract research and development organization (CDMO) that provides outsourced chemistry and biology services to pharmaceutical, biotechnology, specialty chemicals, agrochemical and materials companies worldwide. The firm combines organic synthesis, process development, analytical chemistry, discovery biology and regulatory-compliance support to assist clients across drug discovery and early development, including API work and bioprocess optimization for cell-culture–based programs. Anthem also deploys automated analytical platforms—such as multi-parameter cell culture analyzers capable of measuring chemistry, gases, cell metrics and osmolality—to generate data for bioprocess decision-making. Serving large pharma as well as mid‑size and virtual companies, the company positions itself as a technical partner for developing and scaling compounds and supporting regulatory submissions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

13.3%1Y
%3Y
%5Y

Performance

30.7%1Y
30.6%3Y
30.6%5Y

Volatility

Market cap

5507 M

Market cap (USD)

Daily traded volume (Shares)

66,867

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.88%INR 1,903.50
Divi's Laboratories Limited
Divi's Laboratories Limited Divi's Laboratories Limited Valor: 3132723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.87%INR 9,165.00
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.96%EUR 3.15
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.73%USD 28.97
Strides Pharma Science Ltd
Strides Pharma Science Ltd Strides Pharma Science Ltd Valor: 1071169
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.12%INR 1,023.40
Cipla Ltd
Cipla Ltd Cipla Ltd Valor: 1850620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%INR 1,418.00
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%USD 104.74
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited Valor: 910581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.91%INR 2,994.70
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.49%SEK 52.95
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.22%USD 105.54